Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 25, 2022

SELL
$0.0 - $0.0 $0 - $0
-3,000 Closed
0 $0
Q3 2021

Oct 22, 2021

BUY
$0.0 - $0.0 $0 - $0
1,900 Added 172.73%
3,000 $48,000
Q2 2021

Jul 26, 2021

BUY
$0.0 - $27.0 $0 - $29,700
1,100 New
1,100 $14,000

Others Institutions Holding VINC

About Vincerx Pharma, Inc.


  • Ticker VINC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,189,800
  • Market Cap $6.57M
  • Description
  • Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...
More about VINC
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.